We describe here a family of biomimetic iron carriers that display high binding efficiency for ferric ions and favorable permeation properties across erythrocytic membranes. These carriers inhibit in vitro growth of Plasmodium falciparum by scavenging intracellular iron. The chemical features were realized by reproducing the iron-binding cavities of natural iron carriers (siderophores) and by systematic substitutions of their hydrophilic envelopes for more hydrophobic ones. In contrast to natural carriers, which participate in receptor-mediated iron uptake in cells and act as growth promoters, our synthetic carriers were designed to penetrate cellular membranes by diffusion, scavenge intracellular iron, and thereby act as growth inhibitors. Based on these properties we designate the compounds reversed siderophores and refer to the specific analogs of the natural ferrichrome as synthetic ferrichromes. The antimalarial activity of the synthetic ferrichromes correlated with their lipophilicity, and this antimalarial activity was averted when the chelators were applied as iron(lI) complexes. The sites of synthetic ferrichrome action reside in the intraerythrocytic parasite and not in serum or on normal erythrocyte components. The agents were effective against all stages of parasite growth and against a variety of multidrug-resistant strains of P. falkiparum. The most potent agent of this synthetic ferrichrome series, SF1-ileu, was not toxic to mammalian cells in culture and was 15-fold more potent and 20-fold faster acting than desferrioxamine. Taken in toto, these agents constitute a series of promising candidates for future use in malaria chemotherapy.
Other types of antimalarial agents are urgently needed to combat the global expansion of malaria. This expansion and the resurgence of drug resistance in various regions of the world have prompted the development of innovative chemotherapeutic strategies (see refs. 1-4 for reviews). Because iron is an essential element for virtually all living species (5), the development of compounds that can exert differential sequestration of essential iron(III) could prove useful for arresting parasite growth, including strains of Plasmodium falciparum of demonstrable drug-resistance nature. Previous attempts to use natural and synthetic iron binders as in vitro and in vivo growth inhibitors of intraerythrocytic parasites scored some success (6) (7) (8) (9) (10) (11) (12) (13) (14) . However, each class of compounds thus far examined has had some drawbacks. The hydroxamate-based natural siderophores, which are highly specific chelators, are only moderately efficient antimalarials because oftheir poor permeability into infected erythrocytes, their putative site of action (14) . Synthetic dithiocarbamates and hydroxyquinolines, on the other hand, proved efficacious, apparently because of a combination of high permeation features and metal complexation; however, their propensity for forming cytotoxic metal complexes might curtail their use in vivo (6) (7) (8) (9) (10) . Synthetic catecholates, which acted as specific iron scavengers and showed satisfactory membrane penetration, appeared also of limited use because they demonstrably deplete serum iron pools (11) .
This study focuses on iron(III) carriers that were designed to overcome the above limitations and to display (i) high binding specificity, (ii) requisite permeation properties for gaining rapid access to sensitive intracellular iron sources, and (iii) compartmental selectivity, so as to affect cell iron pools while sparing those in serum.
The chemical design is basically biomimetic, using as a guiding model the natural ferric ion carriers known as siderophores. Siderophores are microbial ferric ion binders of hydrophilic character that bind iron in the medium and transport it into the cell via a receptor-mediated mechanism (15) (16) (17) (18) . We chemically reproduced the iron-binding properties of the siderophores but replaced their hydrophilic envelopes with hydrophobic ones to facilitate penetration into infected erythrocytes. Because the functions of such binders are opposite, or reversed, to those of natural siderophores, we coined the term "reversed siderophores" (RSs) for them.
The RS design was based on a tripodal topology that mimics the natural ferrichrome model (Fig. 1) . These synthetic ferrichromes (SFs) are assembled in a modular fashion with amino acid residues of variable hydrophobicity. Such an approach facilitates systematic chemical modifications for obtaining optimal antimalarial performance. Moreover, by tagging the molecules with fluorescent or radioactive markers, the drug can also be traced in the various cellular compartments (S.D.L. and Z.I.C., unpublished work).
In this work we describe a series of RSs with demonstrable antimalarial activities. These activities are shown to correlate with the lipophilicity and iron-binding capacity of the agents. Antimalarial effect was largely determined by the ability to selectively scavenge intracellular iron(III) from intracellular compartments. The isoleucine RS derivative SF1-ileu was found 15-fold more potent and 20-fold faster acting than the classical desferrioxamine B (Dfo), and it was effective against all stages of parasite development. Although mammalian cells in culture were hardly affected by treatment with these agents, intracellular growth ofP. falciparum strains spanning a wide spectrum of drug resistances was markedly arrested by SF1-ileu and other related congeners. tTo whom reprint requests should be addressed.
MATERIALS AND METHODS

6585
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (19) , as described elsewhere (20) .
Bioassay of Iron Carrier Antimalarial Activity. The antimalarial activity of agents was assayed by adding them from concentrated stock solutions [in dimethyl sulfoxide (DMSO)] to microcultures (24 wells, Costar) containing infected erythrocytes (2.5% hematocrit and 2% parasitemia). The cultures were usually synchronized (4-to 7-hr windows) by incubation in 300 mM alanine/10 mM Tris hydrochloride in conjunction with gelatin flotation (19) and used either at the trophozoite (1-2% parasitemia) or at the ring stage (4-6% parasitemia) of the erythrocytic cycle. After the indicated time of incubation with drug and either before or after washing three times with 100 vol of growth medium, the cells were supplemented with 6 uCi (1 Ci = 37 GBq) of either [3H]hypoxanthine or [3H]isoleucine (Amersham) per well, and parasite growth was assessed after 24-48 hr by harvesting the labeled cells onto glass-fiber filters (Tamar, Jerusalem) (21) and counting the radioactivity.
Effect of Preincubation of Erythrocytes or Plasma with Drug
on Parasite Growth. Erythrocyte suspensions (5% hematocrit) in RPMI 1640 medium, pH 7.4 (no plasma), were treated for 24-48 hr with either chelator at 100 ,g/ml or DMSO alone (<1% final concentration) in culture conditions. Chelator was removed by washing the cells four times with RPMI medium followed by 1-hr incubation at 37°C. Parasite growth was assayed after addition of gelatin-enriched schizonts (>90%) as described above. To deplete serum components from bound iron(III), human plasma (2 ml) from O+ donors was adjusted to either pH 5 with 2-(N-morpholino)ethanesulfonic acid (to enhance iron removal) or pH 7.4 (with Tris base) and treated for 18 hr with chelators at 100 ,ug/ml or with DMSO. The plasma was subsequently dialyzed for 24 hr against 800 (13) . To achieve high binding efficiency and selectivity for iron(III), we adopted the tripodal topology, which is ideal for generating octahedral binding cavities and is common among siderophores, such as enterobactin, ferrichrome, etc. (22) . We, however, replaced the nonsymmetric structure of ferrichrome by a C3-symmetric one, substituted the chiral hexapeptide anchor for a tricarboxylate residue, and compensated the resulting chirality loss by extending the anchor with chiral amino acids (Fig. 1) (Fig. 2 Inset). A compilation of these values for various structural congeners of SF1-ileu is presented in Table 1 .
The efficacy of the agents is clearly primarily correlated with their respective octanol/saline partition coefficient or the hydrophobicity of the amino acid side chain and only secondarily with their iron-binding efficiencies, which are relatively high for all agents. The most potent congener of this series, the isoleucine-containing SF1-ileu, was -6-to 13-fold more efficient than Dfo when administered for 24-to 48-hr exposure periods to various strains of parasites that display a wide spectrum of drug-resistance to antimalarial agents ( Table 2) .
The antimalarial activity of the various chelators was assessed over a 24-hr period of exposure on infected cells (P. falciparum trophozoite stage), as described. W2 and FCR-3 represent chloroquine-resistant strains of P. falciparum, whereas D6 and ItG2G1 strains represent chloroquinesensitive strains.
Mechanism of Inhibition. Plasma and uninfected erythrocytes were separately treated with relatively high concentrations of chelators (100 ,ug/ml) to evaluate whether the site of action of the lipophilic chelators was associated with components ofthe plasma and/or the uninfected erythrocyte. The 24-hr exposure of either plasma or cells to 40-fold higher concentration of the SF1-ileu IC50 followed by washing or dialysis of the free drug was found to have no significant effect on the ability of plasma and cells to support parasite growth (data not shown). This finding demonstrates that the inhibition by the lipophilic iron chelators was at the level of the infected cell. Because in an independent study we observed that lipophilic chelators, such as SF1-ileu, can easily Proc. Natl. Acad. Sci. USA 88 (1991) Proc. Natl. Acad. Sci. USA 88 (1991) 6589 nucleic acid synthesis (Fig. 5) or protein synthesis ([3Hliso-leucine incorporation, data not shown).
CONCLUSIONS
The modular design of another family of iron chelators of defined chemical properties provided a series of antimalarial agents for which efficacy is determined, to a large extent, by the hydrophobic character of the amino acid side chains (Table 1 ). In agreement with these findings is the observation that SF1-ileu, the most potent member of the SF1 series, penetrates rapidly (in the uncomplexed form) into infected erythrocytes (unpublished work). The inhibitory effects of SF1-ileu on DNA and protein synthesis were already manifested within <1/2 hr of exposure of either rings or trophozoites to IC50 concentrations of drug (Fig. 4) . Other SF1s as well as Dfo required >10 hr to elicit substantial inhibitory effects; the trophozoite stage was apparently most susceptible to the antimalarial of these drugs. Site ofaction of the RSs is definitely not either in the serum or on uninfected cells. The most likely site of action is the infected cell, although the precise compartment cannot be specified. SF-ileu displays specificity at four levels: (i) it acts on infected cells while sparing serum iron (i.e., transfemn), (ii) it does not affect irreversibly the ability of uninfected cells to support parasite growth, (iii) it acts swiftly on intracellular parasites, and most important, (iv) it does not affect the growth of mammalian cells in culture. With the knowledge that infected cells have marked but defined changes in host cell membrane permeation properties (2, 19, 27) , it should be possible, in principle, to use the present modular assembly of agents so as to construct RSs with the requisite hydrophobicity and/or molecular dimensions for selective penetration into infected erythrocytes.
